To an immunologist, autoimmune diseases like Type 1 diabetes are the polar opposite of cancer. In the former, the immune ...
n November 23, 2021, the California Institute for Regenerative Medicine (CIRM) governing board approved a $4.1 million grant to enable ...
HOUSTON ― New research from The University of Texas MD Anderson Cancer Center found that treatment with antihistamines, a commonly ...
Children’s National Hospital experts developed a new approach that discovered unique proteins in an individual tumor’s cells, which then helped ...
PHILADELPHIA — Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients ...
Cancer immunotherapy, one of the most important and promising therapies for cancer treatments, is being used by oncologists to treat ...
Alliance for Cancer Gene Therapy (ACGT) Scientific Advisory Council Chair Michael T. Lotze, MD, of the University of Pittsburgh, will ...
It is not an exaggeration to say that immunotherapy has revolutionized cancer treatment. Nor is it boastful to say University ...
Two new studies revealed that anti-PD-1 immunotherapy given before surgery was safe and effective for patients with oral-cavity squamous cell ...
BIRMINGHAM, Ala. – Immunotherapy using checkpoint inhibitors can work well to treat cancer, but only a minority of patients respond ...
Third-generation cancer immunotherapy, a method of removing cancer using the body's immune system, has shown remarkable clinical benefits in recent ...
Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have developed macrophage–tumor chimeric exosomes that ...
Summary: •An antibody delivery technology was developed based on multiple glucosylated polymers conjugated onto antibodies via linkers cleaving in tumor ...
BIRMINGHAM, Ala. – The mix of microbes in the gut can shape a person’s immune response. In immunotherapy for melanoma, ...
Lugano, Switzerland, 18 September 2021 – The addition of immunotherapy to standard first-line treatment extends survival by eight months for patients with recurrent, persistent or metastatic cervical cancer, according to late breaking results from the KEYNOTE-826 ...
PITTSBURGH, Sept. 18, 2021 – An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and ...
Lugano, Switzerland, 18 September 2021 – The first randomised phase III clinical trial in stage II melanoma has shown a 35% reduction in the risk of recurrence with adjuvant pembrolizumab compared with ...
A specially designed lipid nanoparticle could deliver immune-signaling molecules into liver macrophage cells to overcome resistance to anti-tumor immunotherapy.Credit: Takashi ...
A synthetic molecular code shows promise towards improving the response of some cancer patients to immunotherapy treatments. The approach involves ...
CHAPEL HILL, NC—A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center ...
